Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma (NCT03057626)

🧪 Interventions in This Study

• Cytology Specimen Collection Procedure (OTHER)
• Laboratory Biomarker Analysis (OTHER)
• Quality-of-Life Assessment (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (98 Sites)

Showing the first 25 of 98 sites.

• Children's Hospital of Alabama — Birmingham, Alabama
• Phoenix Childrens Hospital — Phoenix, Arizona
• Arkansas Children's Hospital — Little Rock, Arkansas
• Kaiser Permanente Downey Medical Center — Downey, California
• City of Hope Comprehensive Cancer Center — Duarte, California
• Children's Hospital Los Angeles — Los Angeles, California
• UCSF Benioff Children's Hospital Oakland — Oakland, California
• Kaiser Permanente-Oakland — Oakland, California
• Lucile Packard Children's Hospital Stanford University — Palo Alto, California
• UCSF Medical Center-Mission Bay — San Francisco, California
• Children's Hospital Colorado — Aurora, Colorado
• Connecticut Children's Medical Center — Hartford, Connecticut
• Yale University — New Haven, Connecticut
• Alfred I duPont Hospital for Children — Wilmington, Delaware
• Children's National Medical Center — Washington D.C., District of Columbia
• Broward Health Medical Center — Fort Lauderdale, Florida
• Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida
• University of Florida Health Science Center - Gainesville — Gainesville, Florida
• Nemours Children's Clinic-Jacksonville — Jacksonville, Florida
• AdventHealth Orlando — Orlando, Florida
• Arnold Palmer Hospital for Children — Orlando, Florida
• Nemours Children's Hospital — Orlando, Florida
• Johns Hopkins All Children's Hospital — St. Petersburg, Florida
• Saint Joseph's Hospital/Children's Hospital-Tampa — Tampa, Florida
• Children's Healthcare of Atlanta - Egleston — Atlanta, Georgia

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Recurrent Neuroblastoma

• Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma — Los Angeles, California

Explore by condition: All Recurrent Neuroblastoma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.